Terms: = Kidney tumors AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Clinical Outcome
407 results:
1. Spreading Through Air Spaces And Thinking About Lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
2. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
3. Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma.
Numakura K; Igarashi R; Takahashi M; Nara T; Kanda S; Saito M; Narita S; Inoue T; Niioka T; Miura M; Habuchi T
Cancer Biol Ther; 2024 Dec; 25(1):2312602. PubMed ID: 38327067
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics and clinical outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract] [Full Text] [Related]
5. Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer.
Poinot H; Dupuychaffray E; Arnoux G; Alvarez M; Tachet J; Ezzar O; Moore J; Bejuy O; Olesti E; Visconti G; González-Ruiz V; Rudaz S; Tille JC; Voegel CD; Nowak-Sliwinska P; Bourquin C; Pommier A
Oncoimmunology; 2024; 13(1):2286820. PubMed ID: 38170044
[TBL] [Abstract] [Full Text] [Related]
6. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
[TBL] [Abstract] [Full Text] [Related]
7. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
8. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract] [Full Text] [Related]
9. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
10. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
11. Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer.
Gau D; Daoud A; Allen A; Joy M; Sagan A; Lee S; Lucas PC; Duensing S; Boone D; Osmanbeyoglu HU; Roy P
J Biol Chem; 2023 Aug; 299(8):105044. PubMed ID: 37451478
[TBL] [Abstract] [Full Text] [Related]
12. Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab.
Matsumura S; Kato T; Kujime Y; Kitakaze H; Nakano K; Hongo S; Yoshioka I; Okumi M; Nonomura N; Takada S
BMC Urol; 2023 Jun; 23(1):107. PubMed ID: 37301837
[TBL] [Abstract] [Full Text] [Related]
13. Remarkable 107-year-old kidney with a 49-year of long-term allograph survival through continuous azathioprine monotherapy.
Nascimento E; Filho AS; Lucas-Junior FDM; Jobim LFJ; Lasmar MF; Tavares-Filho HA; Fabreti-Oliveira RA
Transpl Immunol; 2023 Jun; 78():101821. PubMed ID: 36921732
[TBL] [Abstract] [Full Text] [Related]
14. Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Behrendt CE; Villalona-Calero MA; Newman EM; Frankel PH
Contemp Clin Trials; 2023 Feb; 125():107083. PubMed ID: 36638911
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of Cyclin F Promotes Cellular Senescence through Cyclin-dependent Kinase 1-mediated Cell Cycle Regulation.
Li X; Li YJ; Wang MJ; Ou KP; Chen YQ
Curr Med Sci; 2023 Apr; 43(2):246-254. PubMed ID: 36602672
[TBL] [Abstract] [Full Text] [Related]
16. Differential Expression of RSK4 Transcript Isoforms in Cancer and Its clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract] [Full Text] [Related]
17. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
18. Identifying Prognostic Biomarkers Related to m6A Modification and Immune Infiltration in Renal Cell Carcinoma.
Ye J; Li P; Zhang H; Wu Q; Yang D
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360294
[TBL] [Abstract] [Full Text] [Related]
19. Safety, Efficacy, and Predictors for Late Reintervention After Embolization of Renal Angiomyolipomas - Embolization renal angiomyolipoma.
Claesen E; Bonne L; Laenen A; Bammens B; Albersen M; De Wever L; Maleux G
Rofo; 2023 Apr; 195(4):319-325. PubMed ID: 36270316
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of Talin-1 in renal cell carcinoma and its association with B7-H3.
Saeednejad Zanjani L; Vafaei S; Abolhasani M; Fattahi F; Madjd Z
Cancer Biomark; 2022; 35(3):269-292. PubMed ID: 36245369
[TBL] [Abstract] [Full Text] [Related]
[Next]
